blood cancer

Sign warning about erosion on a cliff
Biotech

Gilead's Kite erodes $2.3B Shoreline cell therapy deal

The pact to pursue off-the-shelf CAR-NK therapies for blood cancers ended in the first quarter of this year, a Gilead spokesperson confirmed.
Darren Incorvaia Sep 3, 2025 3:18pm
An arrow incrementally going up stairs before pointing straight up Blue background

BeOne asset hits primary endpoint, tees up blood cancer filings

Aug 29, 2025 9:50am
Graphic of a drop of blood made up of small data points and nodes

J&J lymphoma CAR-T hits 100% ORR in 10 patients

Jun 13, 2025 1:22pm
rainbow kite flying in the sky

ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study

May 31, 2025 7:00pm
Yellow arrow going opposite direction as white arrows

BioNTech passes on Autolus' CAR-T amid pipeline prioritization

Mar 20, 2025 9:11am
whale jumping out of water

Orca prepares to make market plunge after phase 3 win

Mar 17, 2025 7:00am